CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 8-K Event Executive or director change
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 1,545 shares at an average $26.61 ($41,115)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 403 shares at $17.33 ($6,983)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 767 shares at $17.33 ($13,290)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award EVP, CHIEF BUSINESS OFFICER acquired 37,593 shares (grant or award)
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 31,709 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 53,499 shares (grant or award)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 302 shares at $17.63 ($5,323)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 1,744 shares at $25.70 ($44,821)
- 4 Open-market sale CEO sold 18,252 shares at $26.95 ($491,979)
Page 15 of 37 · 731 filings